Introduction
Experimental and clinical cancer gene therapy strategies were first developed by using transduction of the thymidine ( ) kinase gene of the herpes simplex virus type 1 HSV- The vast majority of therapeutic genes, however, do not have appropriate marker substrates that can be radiolabeled or would accumulate in transduced tissues to a level that could be detected by noninvasive imaging. Therefore, it is necessary to develop indirect imaging strategies for monitoring the expression of different therapeutic genes. This can be achieved by functional coexpression of marker and therapeutic genes. The most important requirement of this approach is a proportional and constant coexpression of the ( ) marker gene HSV-1-tk or gfp and ''therapeutic'' gene over the wide range of expression levels. Proportionality of coexpression may be achieved by using an internal ribosome ( ) [ ] entry site IRES element of picornaviruses 30 to link the two genes in an expression cassette under control of a [ ] single promoter 31 -35 . A more direct approach, is to produce a fusion gene that would encode for a ''marker/ [ ] therapeutic '' fusion protein 36,37 . In this report, we describe a paradigm for monitoring the expression of therapeutic transgenes that retain functional activity when coexpressed as a fusion protein. This can be achieved when both the therapeutic and marker subunits of the fusion protein retain functional activity. In this context, we constructed a tkgfp fusion gene and assessed the ( ) proportionality of HSV-1 thymidine kinase TK and green ( ) fluorescent protein GFP activity over the wide range of expression levels in transduced cells in culture.
Materials and Methods

Cell Culture
[ ] Rat 9L gliosarcoma cells 38 were grown as monolayers ( in Dulbecco's modified Eagle medium DMEM; Mediatech, ) Washington, DC supplemented with 10% fetal bovine serum ( ) FBS; Sigma, St. Louis, MO and 100 U / mL penicillin and ( ) 100 mg / mL streptomycin P / S; Sigma . The RG2 and W256 cell lines were grown in MEM supplemented with 10% FBS and antibiotics. All cells were grown at 378C in a 5% Carbon dioxide/ 95% air atmosphere.
Cloning of the tkgfp Fusion Gene
The cDNA encoding the thymidine kinase gene of HSV- 1.2-kb tk fragment was isolated and ligated to the 4.7-kb ( DNA fragment obtained after plasmid pEGFP-N1 Invitro-) gen was digested sequentially with BglII and XmaI. After ligation, the open reading frames of both tk and gfp are ( ) in-frame within the pTKGFP expression plasmid 5.9 kb , placing the tkgfp cDNA under control of the cytomegalo-( ) ( ) ( ) virus CMV immediate early IE 1 promoter Figure 1 . 
Cloning of the tkgfp Fusion Gene into a Retroviral Vector
Retroviral Transduction of Tumor Cell Lines
The rat RG2 glioma and rat W256 carcinoma cells were exposed to the medium containing SFG-TKGFP retrovirus ( 6 ) ( ) ; 10 / mL in presence of polybrene 8 mg/mL for 8 hours. GFP-positive transduced RG2TKGFP q and W256TKGFPq cells were detected by fluorescence microscopy. Single-cell-derived clones were obtained from a mixed population of transduced RG2TKGFPq and W256 TKGFPq cells by seeding the cells into the 96 well plates at a density of 0.1 cell / well. GFP-positive RG2TKGFPq and W256 TKGFPq colonies were identified by fluorescence microscopy and used for further propagation into single-cell-derived clonal populations.
Functional Assessment of pTKGFP
The initial functional assessment of the tkgfp gene construct included the determination of green fluorescence and ( ) ganciclovir GCV -sensitivity in transiently transfected rat 9L gliosarcoma cells in culture. For both evaluations, 80% ( ) confluent monolayers of 9L cells 600,000/ 35mm dish were transfected with the plasmid pTKGFP or control plasmids ( ) pHSV-TK and pHSV-GFP see the next section or no ( ) vector with lipofectamine GIBCO BRL , according to the ( manufacturer's protocol 1 mg DNA q6 ml lipofectamine per ) 35-mm dish . For fluorescent detection of gfp-expressing cells, culture plates were examined with a standard fluores-( cence microscope Zeiss IM35; Carl Zeiss Inc, Thornwood, ) NY 24 hours after transfection. For determination of the ganciclovir sensitivity, GCV-treatment was carried out at final concentrations of 0, 0.1, 0.3, 1, 3 and 9 mg / mL medium for half of the dishes starting 24 hours after transfection. Four days later, surviving 9L cells were determined as a percentage of non -GCV-treated transfected cells. A ( ) tk-bearing HSV-1 amplicon plasmid pHSV-TK, 11.8 kb featuring the tk gene under control of the CMV IE1 pro-( ) moter Figure 1 and an HSV-1 amplicon plasmid containing ( gfp under control of the CMV IE1 promoter pHSV-GFP; ) 10.4 kb; Figure 1 served as positive controls. All experiments were performed in triplicate and repeated 3 times.
Functional Assessment of GFP Expression in Transduced Clones
The [ 3 ] pure. The concentrations of 2-C -FIAU and methyl-H -( ) TdR thymidine deoxyribose were 0.01 and 0.1 mCi / mL, respectively. The cells were harvested by using a scraper ( after various periods of incubation 10, 30, 60, 90, and 120 ) minutes , weighed, and assayed with a Packard B1600 TriCarb b-spectrometer and standard 3 H and 14 C dual-channel counting techniques. The medium was counted before and after incubation. The data were expressed as a ( ) harvested cell-to-medium concentration ratio dpm / g cells / (
) [ ] dpm / mL medium and plotted against time 22 . The steady-state accumulation rate of FIAU, normalized by that of TdR, was obtained from the slopes of the plot and used ( as a measure of HSV-1-tk gene expression in culture FIAU ) /TdR ratio .
Western Blot Analysis
The expression of TK and GFP were evaluated by Western blotting with a rabbit polyclonal HSV-TK antiserum and ( ) a rabbit anti-GFP antibody CLONTECH, Palo Alto, CA . Twenty-four hours after transfection of 4 mg each of purified ( ) pTKGFP, pHSV-TK positive control for TK , or pHSV-GFP ( ) positive control for GFP into 9L cells, monolayers were harvested and resuspended in phosphate buffered saline ( ) [ ] 1 = PBS and processed as described previously 44 . In brief, after cell lysis, samples were boiled for 5 minutes and electrophoresed on denaturing 10% acrylamide gels overnight. Proteins were transferred to a Hybond-ECL mem-( ) brane Amersham, Arlington Hts., IL by standard tank ( ) transfer in Tris-glycine transfer buffer at 45 V 0.5 mA for 3 hours. Nonspecific membrane binding was blocked by incubating the membrane in 10% nonfat dry milk in PBS-Tween ( ) overnight. After washing 3 = , the membrane was incu-( bated with primary antibodies anti-TK 1:1000 and anti-GFP ) 1:1000, respectively, in 1% nonfat dry milk / PBS-Tween for ( ) 1 hour at room temperature. After washing 3 = , the membrane was incubated with horseradish peroxidase -( ) conjugated horse antirabbit 1:4000 immunoglobulin in blocking solution for 1 hour, then washed, and developed by ( ) using the ECL reagents Amersham .
Statistical Analyses
The mean values" SD of cell counts and the percent differences between GCV-treated and nontreated dishes were calculated and results plotted with the software package SigmaPlot 1.02. The analysis of coexpression of HSV-1-tk and gfp genes was done with StatView 4.57 ( ) ( Abacus Concepts, CA and Kaleidagraph 3.08 Synergy ) Software, CA .
Results
The tkgfp Fusion Gene was Cloned in Frame Under Control of CMV IE1 or Retroviral LTR Promoters
The expression plasmid pTKGFP bears the HSV-1-tk gene in-frame to the gfp gene under control of the CMV IE ( ) ( ) promoter 
The Levels of gfp-Expression are Comparable in Cells Transduced with tkgfp and Native gfp Genes
In order to compare the levels of gfp-expression, plasmids pTKGFP and pHSV-GFP were transfected into rat 9L gliosarcoma cells. The levels of gfp-expression were assessed 1, 2, 3, and 5 days after transfection with a standard fluorescence microscope and were visually of similar inten- [ ] 36 , the intracellular expression pattern of the TKGFP seems different than the native GFP. TKGFP is mostly concentrated in the nucleus, whereas the native GFP displays a predominantly cytoplasmic distribution.
GCV-Sensitivity is Similar in pTKGFP and pHSV-TK Transfected 9L Cells
In order to investigate the ability of the TKGFP fusion protein to mediate significant sensitivity towards the pro-drug ganciclovir, pTKGFP and pHSV-TK transduced 9L glioma ( ) cells positive control were treated with different amounts of GCV ranging from 0 to 9 mg / mL over a 5-day exposure period. After the treatment period, surviving cells were determined as a percentage of non -GCV-treated controls. In contrast to pHSV-GFP and nontransfected negative controls, the pTKGFP and pHSV-TK transfected 9L cells were both sensitive to GCV in a similar dose-dependent manner ( ) Figure 4 .
Coexpression of gfp and HSV-1-tk Genes
To investigate the spectrum of transgene coexpression that is achieved in polyclonal cell populations, we generated two series of clones to examine coexpression of both genes in the context of fusion gene expression. We obtained multiple retrovirally transduced RG2TKGFP q and W256TKGFPq clones with different levels of transgene ( expression due to different genomic sites of retroviral inte-) gration to explore coexpression over a broad range of transgene expression levels. The proportionality of the HSV-1-tk and gfp gene expression was assessed in culture by using the radiotracer and FACS assays, respectively. For FACS analysis of GFP, the range of fluorescence was set to include no more than 1% of corresponding control cells ( ) Figure 5 . The mean GFP fluorescence per cell was used as a measure of GFP expression in a clonal population of transduced cells. Regression analysis demonstrated a strong relationship between the levels of expression of gfp and HSV-1-tk genes in corresponding clones of retrovirally ( ) transduced RG2 glioma cells RG2TKGFPq ; Figure 6A ( ) and in W256 carcinoma cells W256TKGFPq ; Figure 6B . Combining the RG2TKGFPq and W256TKGFPq data sets yields a similar relationship over a wide range of transgene ( ) expression levels Figure 6C . Statistical analysis of the combined data also revealed that there was a significant ( correlation between the HSV-1-tk and gfp expression r s 0.894; P -.0001; and t s 2.477; P -.05 based on paired ) t-test analysis . This suggests that the relationship of fusion gene-mediated coexpression is independent of tissue type.
The TKGFP Protein is Recognized by Both Anti-TK and Anti-GFP Antibodies
In order to investigate the tkgfp fusion gene expression at the protein level, cellular proteins of pTKGFP, pHSV-GFP, and pHSV-TK-transfected 9L cells harvested at 24 hour after transfection were resolved by SDS-PAGE and analyzed on Western blots by using antibodies to TK and GFP ( ) Figure 7 . The predominant band recognized by both the TK and the GFP antibodies is 66 kD, the appropriate size of the TKGFP fusion protein. TK and GFP proteins are, as expected, recognized only by their specific antibodies and ( maintain their native size approximately 46 kD and 27 kD, ) respectively .
Discussion
The paradigm for noninvasive imaging of therapeutic gene expression that we propose in this report relies on proportional coexpression of a ''marker'' gene and a ''therapeutic'' gene products. Usually, the coexpression of two gene products is achieved by using a dual-promoter approach. However, on an individual cell level, as opposed to cell populations in which total expression is averaged, proportional coexpression may be compromised because of promoter interference or transcriptional repression. The proportionality of IRES-mediated coexpression of two genes is determined at the translational level and depends on protein synthetic activity and cell cycle phase of the transduced [ ] ( ) cells 45 . Strictly proportional equimolar coexpression of two genes under control of a single promoter can be achieved by using fusion gene approach.
To assess whether the fusion gene approach is applicable to the described imaging paradigm, we constructed the tkgfp fusion gene consisting of the HSV-1-tk marker gene Most importantly, we demonstrated that fusion gene approach provides a constant relationship between the expression of the HSV-1-tk and gfp genes over a wide range of expression levels. Thus, noninvasive images of HSV-1-tk expression should reflect distribution and level of expression of gfp or different therapeutic genes. Parametric images of therapeutic gene expression could be generated if the relationship between the levels of FIAU accumulation ( ) HSV-1-tk expression and functional measures of therapeutic gene expression in transduced tissues are known.
Limitations of the fusion gene-fusion protein approach is that is cannot be applied to proteins that may loose functionality as the result of fusion or will not be able to localize to the appropriate subcellular compartment. This approach ( cannot be applied to secretory proteins e.g., cytokines, ) growth factors because the HSV-1-tk marker enzyme should remain intracellular in order to catalyze the intracellular accumulation of radiolabeled FIAU. Potentially higher immunogenicity of fusion proteins may also limit their application in in vivo studies.
The tkgfp fusion gene can also be considered as therapeutic-marker gene construct, where tk is used as therapeutic gene and gfp as marker gene for in situ detection or direct visualization. GFP is the most widely used marker protein for direct visualization of transgene expression in living cells and transparent tissues and organisms in vivo [ ] [ ] 46 -54 . Recently, Flotte et al. 53 implemented a videoendoscopy technique for direct visualization of gfp-transduced airway epithelium. Similar endoscopic technique for visualization of tkgfp fusion gene expression could be useful for gene therapy directed to the gastrointestinal tract by using the HSV-1-tk/ GCV paradigm. Therefore, tkgfp fusion gene could be used as a dual-marker gene for noninvasive imaging, direct endoscopic visualization, and in situ detection with fluorescence microscopy.
From a vector design prospective, the tkgfp fusion gene has several positive features. A relatively small coding re-( ) ( ) gion of tk 1.2 kb and gfp 750 bp results in a tkgfp fusion gene that is less than 2 kb in size and allows for easy incorporation into virus vectors with small transgene capaci-( ) ties e.g., adeno-associated virus vector . The transgene capacity of adeno-associated virus vectors is less than 5 kb, ( which makes cloning of two transgenes therapeutic and ) selection gene within the same vector difficult. The GFP-fluorescence is not dependent on substrates or cofactors, which enables direct detection of transgene expression in living cells. Therefore, the need for time-consuming immunocytochemistry and histochemistry for the detection of transduced cells can be avoided. This is particularly important because of the lack of a readily available antibody for HSV-1-tk. Furthermore, GFP-expressing cells can be rapidly isolated from a pool of transduced cells by FACS. This avoids time-consuming drug selection and allows for fractionation of cells with respect to the level of GFP expression and, in turn, the level of tk expression.
Summary
The proportionality of coexpression of two genes in fusion, the HSV-1-tk and gfp, was demonstrated over the wide range of expression levels. Fusion gene approach should be applicable to the paradigm of monitoring therapeutic transgene expression by noninvasive imaging of marker gene coexpression. Noninvasive imaging of transgene expression should facilitate assessment of the efficacy and target specificity of novel gene delivery vectors by defining the distribution, level, and temporal profile of expression of different therapeutic genes in vivo. It would contribute significantly to further development of vector technology and gene therapy in general.
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